Dravet syndrome is a severe epileptic encephalopathy mainly caused by heterozygous mutations in the SCN1A gene encoding a voltage-gated sodium channel Nav1.1. We previously reported dense localization of Nav1.1 in parvalbumin (PV)-positive inhibitory interneurons in mice and abnormal firing of those neurons in Nav1.1-deficient mice. In the present study, we investigated the physiologic consequence of selective Nav1.1 deletion in mouse global inhibitory neurons, forebrain excitatory neurons or PV cells, using vesicular GABA transporter (VGAT)-Cre, empty spiracles homolog 1 (Emx1)-Cre or PV-Cre recombinase drivers. We show that selective Nav1.1 deletion using VGAT-Cre causes epileptic seizures and premature death that are unexpectedly more severe than those observed in constitutive Nav1.1-deficient mice. Nav1.1 deletion using Emx1-Cre does not cause any noticeable abnormalities in mice; however, the severe lethality observed with VGAT-Cre-driven Nav1.1 deletion is rescued by additional Nav1.1 deletion using Emx1-Cre. In addition to predominant expression in PV interneurons, we detected Nav1.1 in subpopulations of excitatory neurons, including entorhino-hippocampal projection neurons, a subpopulation of neocortical layer V excitatory neurons, and thalamo-cortical projection neurons. We further show that even minimal selective Nav1.1 deletion, using PV-Cre, is sufficient to cause spontaneous epileptic seizures and ataxia in mice. Overall, our results indicate that functional impairment of PV inhibitory neurons with Nav1.1 haploinsufficiency contributes to the epileptic pathology of Dravet syndrome, and show for the first time that Nav1.1 haploinsufficiency in excitatory neurons has an ameliorating effect on the pathology.
INTRODUCTION
Heterozygous mutations in the SCN1A gene, which encodes a voltage-gated sodium channel a I subunit (Nav1.1), are associated with a wide spectrum of childhood epilepsies, including generalized epilepsy with febrile seizures [Mendelian Inheritance in Man (MIM) #604233], and Dravet syndrome (MIM #607208) (1) (2) (3) (4) (5) (6) (7) (8) . Dravet syndrome is an intractable epileptic encephalopathy characterized by early onset epileptic seizures, mental retardation, autistic behaviors, ataxia and increased risk of sudden unexpected death in epilepsy (SUDEP) (9, 10) . Nav1.1 haploinsufficiency has been implicated in Dravet syndrome pathology (11) (12) (13) and in mice, causes epileptic seizures, ataxia (14, 15) , learning/memory impairments and abnormal social behaviors (16, 17) . Previously, we showed dense Nav1.1 expression at the axons and soma of parvalbumin (PV)-positive interneurons, a subclass of GABAergic inhibitory neurons, in the hippocampus and neocortex. In Scn1a heterozygous knock-out mice, these cells exhibit pronounced spike amplitude decrements in trains of evoked action potentials. Therefore, based on these observations, we proposed that impaired functions of PV interneurons arising from Nav1.1 haploinsufficiency contribute to the generation of seizures in patients with Dravet syndrome (15) . A recent study confirmed predominant Nav1.1 expression in PV interneurons (18) .
Cheah et al. (19) recently reported spontaneous epileptic seizures in mice with a conditional Nav1.1 deletion mediated by the distal-less homeobox (Dlx)1/2-l12b enhancer + b-globin promoter Cre driver (Dlx1/2-Cre) (19) , which express Cre recombinase selectively in nearly all forebrain GABAergic inhibitory neurons (20) . Subsequently, Dutton et al. (18) reported increased flurothyl-and hyperthermia-induced seizure susceptibilities in mice with conditional Nav1.1 inactivation, mediated by the protein phosphatase 1 regulatory subunit 2 (Ppp1r2) promoterdriven Cre driver (Ppp1r2-Cre) (18) , which express Cre recombinase in a subset of forebrain GABAergic neurons mainly consisting of PV interneurons, but also including reelin-and neuropeptide Y-positive inhibitory neurons (21) . Dutton et al. (18) also showed that Emx1-Cre-dependent Nav1.1 inactivation did not alter flurothyl-and hyperthermia-induced seizure susceptibilities in mice. These studies provide important insights into the functional roles of neuronal subtypes in the epileptic pathology of Dravet syndrome. However, much remains to be investigated, including the effect on the epileptic pathology, of Nav1.1 deletion in PV cells.
Here, we report that selective Nav1.1 deletion in global inhibitory neurons, via VGAT-Cre recombination, causes severe epileptic seizures and sudden death in mice. Although previous studies show that Ppp1r2-Cre or Dlx1/2-Cre-driven elimination of Nav1.1 leads to comparable or even milder phenotypes, compared with constitutive Scn1a knock-out mice (18, 19) , our VGAT-Cre-driven elimination of Nav1.1 in global inhibitory neurons results in a more severe phenotype than constitutive Scn1a knock-out mice. Furthermore, we show that additional Nav1.1 deletion in mouse excitatory neurons, using Emx1-Cre recombination, does not cause any noticeable abnormalities on its own, but improves the severe phenotype observed in mice with VGAT-Cre-dependent Nav1.1 deletion. In addition, we show that a minimal amount of PV-Credriven Nav.1.1 deletion is sufficient to cause spontaneous epileptic seizures and ataxia in mice. These results indicate that Nav1.1 haploinsufficiency in excitatory neurons has an ameliorating effect in Dravet syndrome, and support our previous proposal that functional impairment of PV interneurons is the cellular/ circuit basis of epileptic pathology in Dravet syndrome (15) .
RESULTS

Generation of mice with a floxed Scn1a allele
We generated mice with a floxed Scn1a allele, containing two loxP cassettes placed on either side of coding exon 7 ( Fig. 1A and Supplementary Material, Fig. S1 ). Mice homozygous for the floxed allele (Scn1a fl/fl ) were viable with no obvious abnormal phenotypes, and expressed normal Nav1.1 levels in the brain (Fig. 1B) . Next, we generated mice with a constitutively deleted Scn1a allele by crossing Scn1a fl/fl mice and EIIa-Cre mice, in which the Cre-loxP recombination occurs in germline cells ( Fig. 1A and C) (22) . Homozygous (Scn1a d/d ) progeny were viable with no obvious abnormal phenotypes in the first postnatal week. However, the mice developed severe ataxia at around postnatal day 10 (P10) and generalized convulsive seizures around P12 ( Fig. 1D and E) . Scn1a d/d mice also developed malnutrition in the third postnatal week, probably due to ataxia and recurrent seizures, and died before P20 with an average lifespan of 16.2 days (n ¼ 19) (Fig. 1F) . Heterozygous (Scn1a d/+ ) progeny were viable with no obvious abnormal phenotypes until the beginning of the third postnatal week. By the end of the third postnatal week, the mice developed recurrent seizures. Some Scn1a d/+ mice suffered sporadic sudden death after P18, and 25.0% (9 of 36) died before P90 (Fig. 1F ). These clinical manifestations of Scn1a d/d and Scn1a d/+ mice are virtually identical to those previously reported in Nav1.1-null mice (14, 15) , indicating that mice carrying the floxed Scn1a allele can serve as useful tools for the dissection of the physiologic consequences of Nav1.1 deletion, in genetically defined neuronal subtypes, using the Cre-loxP system. Selective Nav1.1 deletion in global inhibitory neurons in mice causes epileptic seizures with higher lethality than constitutive knock-outs
To assess the physiologic consequences of Nav1.1 deletion in global GABAergic neurons, we generated a BAC transgenic mouse line with Cre recombinase expression under the control of the promoter for vesicular GABA transporter (VGAT) that is expressed in glycinergic and GABAergic inhibitory neurons (23, 24) (Fig. 2A) . The Vgat-Cre BAC transgenic (VGAT-Cre) mice were viable with no obvious abnormal phenotypes. Immunohistochemical investigation of VGAT-Cre,Rosa26-LacZ double-mutant mice (25) revealed that transgenic Vgat promoterdriven Cre-loxP recombination occurred widely in brain tissue, including the olfactory bulb, striatum, neocortex, hippocampus, cerebellum, medulla and pons (Fig. 2B) . Immunofluorescent examination showed b-galactosidase immunosignals present in 96.5% (1816 of 1882) and 93.8% (422 of 450) of GABA-positive cells in the hippocampus and neocortex, respectively ( Fig. 2C-J) , suggesting transgenic Vgat promoter-driven Cre-loxP recombination occurred globally, in whole populations of GABAergic neurons. Conversely, 99.0% (1816 of 1835) and 88.5% (422 of 477) of b-galactosidase-positive cells were positive for GABA in the hippocampus and neocortex, respectively, suggesting transgenic Vgat promoter-driven Cre-loxP recombination may be restricted to global inhibitory neurons.
We next generated mice with heterozygous Nav1.1 deletion in global inhibitory neurons (Scn1a fl/+ ,VGAT-Cre) by crossing Scn1a fl/fl and VGAT-Cre mice. PCR analysis of DNA from Scn1a fl/+ ,VGAT-Cre whole brain verified VGAT-Cre-dependent recombination of the floxed Scn1a allele (Fig. 3A) . Western blot analysis showed Nav1.1 expression in P21.5 Scn1a fl/+ , VGAT-Cre whole brain was reduced to 72.3 + 3.4% level of that in Scn1a fl/+ mice ( Fig. 3B and C) . Until the second postnatal week, Scn1a fl/+ ,VGAT-Cre mice were viable and physically indistinguishable from Scn1a fl/+ mice, but at around P16 the mice developed spontaneous generalized convulsive seizures ( Fig. 3D and E) , which occasionally led to immediate death. In all three recorded lethal seizure cases, postictal electrocorticography (ECoG) activity progressively decreased, becoming undetectable within a minute after the end of the seizure (Fig. 3E) . Maintenance of postictal ECoG activity until recovery from postictal immobility and ECoG suppression ensured generalized convulsions did not lead to death. Remarkably, all but one (64 of 65; 98.5%) Scn1a fl/+ ,VGAT-Cre mice died before P35 (Fig. 3F ), and their under-P35 mortality rate was significantly higher than constitutive heterozygous Scn1a knock-out mice (Scn1a We also generated mice with homozygous Nav1.1 deletion in global inhibitory neurons (Scn1a fl/fl ,VGAT-Cre) (see Materials and Methods) (Fig. 3G) . Western blot analysis showed that Nav1.1 expression in P12.5 Scn1a fl/fl ,VGAT-Cre whole brain was reduced to 57.6 + 9.9% level of that in Scn1a fl/fl mice ( Fig. 3H and I ). Scn1a fl/fl ,VGAT-Cre mice were viable and showed no obvious abnormalities until around P10. However, after approximately P11, the mice exhibited behavioral hypoactivity, except for periodic myoclonus-like jerky movements, and all died before P15 (Fig. 3F) ,VGAT-Cre mice did not develop severe ataxia and walked normally until a day before their death.
We used immunohistochemistry to examine the spatial pattern of Nav1.1 expression in P12.5 Scn1a fl/fl ,VGAT-Cre brain (Fig. 4) , using an anti-Nav1.1 antibody whose specificity has been verified using Nav1.1-null mice as negative controls (15) . P12.5 was the oldest age used because of the high mortality rate beyond P10 and the short life expectancy (within P15). In the hippocampus of Scn1a fl/fl controls, Nav1.1-immunoreactive fibers and puncta were scattered throughout the CA fields (Fig. 4A) . In contrast, in Scn1a fl/fl ,VGAT-Cre mice, Nav1.1-immunoreactive fibers and puncta were mostly undetectable (Fig. 4B) . Similarly, in the neocortex, Nav1.1-immunoreactive fibers and puncta were scattered throughout neocortical layers II/III, IV, V and VI in Scn1a ,VGAT-Cre mice ( Fig. 4C and D) .
In the cerebellum at P12.5, differences in Nav1.1 immunostaining patterns and intensities between Scn1a fl/fl and Scn1a fl/fl , VGAT-Cre mice were also observed ( Fig. 4E and F) , even though Scn1a fl/fl ,VGAT-Cre mice did not develop ataxia. Nav1.1-immunoreactive fibers in the inner molecular layer of the cerebellar lobes, presumably axons of cerebellar basket ,VGAT-Cre mice may explain the absence of apparent ataxia in these mice.
Selective Nav1.1 deletion in forebrain excitatory neurons does not cause epileptic seizures in mice To determine whether excitatory neurons express Nav1.1, and if they do, what is their role in epileptic phenotypes, we employed the empty spiracles homolog 1 (Emx1)-Cre knock-in mouse expressing Cre recombinase under the control of the endogenous Emx1 promoter (26) . Emx1 is a marker for cortical pyramidal cells and glia, and is not expressed in GABAergic cells (27, 28) . In the Emx1-Cre mouse, Cre recombinase is expressed in pallium-derived excitatory neurons in various brain regions, including the olfactory bulb, neocortex, piriform cortex, entorhinal cortex, hippocampus and amygdala (26) .
PCR analysis of DNA from Scn1a fl/fl , Emx1-Cre whole brain verified Emx1-Cre-dependent recombination of the floxed Scn1a allele (Fig. 5A) . Western blot analysis showed that Nav1.1 expression in Scn1a fl/fl , Emx1-Cre whole brain was reduced to 72.1 + 1.7 and 63.4 + 2.3% levels of those in Scn1a fl/fl mice at P21.5 and 8 weeks, respectively ( Fig. 5B and C) . Homozygous (Scn1a fl/fl , Emx1-Cre) mice were viable and with no noticeable abnormal phenotype, including no convulsive seizures (Fig. 5D ).
Nav1.1 is expressed in subpopulations of excitatory neurons
The spatial and temporal patterns of Nav1. immunohistochemistry. In the hippocampus at P21.5, Nav1.1-immunoreactive fibers and puncta were clearly observed in the stratum oriens and pyramidal layers of the CA fields, in both Scn1a fl/fl and Scn1a fl/fl , Emx1-Cre mice ( Fig. 6A and B ). In the neocortex at P21.5, Nav1.1-immunoreactive fibers and puncta appeared to be distributed similarly in Scn1a fl/fl and
Scn1a
fl/fl , Emx1-Cre mice; however, subtle differences were detected ( Fig. 6C and D) . In neocortical layer V of Scn1a fl/fl controls, Nav1.1 immunoreactivity was detected in the proximity of neurites oriented toward the pial surface (upward), presumably AISs of PV interneurons, and also in the proximity of basal neurites oriented toward the ventricular surface (downward), of a , VGAT-Cre mice and age-matched Scn1a fl/fl controls, using anti-Nav1.1 antibody. Two independent assays were performed. Error bars represent SEM.
* P , 0.05, * * P , 0.01. +, wild-type allele; fl, floxed allele; d, deleted allele.
neuronal subpopulation with large Nav1.1-immunopositive somata (Fig. 6Cb ). These Nav1.1-immunoreactive downward basal neurites were not observed in other neocortical layers. In contrast, in Scn1a fl/fl , Emx1-Cre mice, Nav1.1 immunoreactivity was occasionally detected in upward, but rarely in downward, neurites (Fig. 6Db ). These observations suggest that cells with Nav1.1-positive downward basal neurites are excitatory pyramidal neurons. Therefore, we performed double-immunolabeling of neocortices in Gad67-GFP mice, expressing GFP in global inhibitory neurons (29) , using anti-Nav1.1 and -GFP antibodies. We detected Nav1.1 immunoreactivity in proximal neurites of neocortical GFP-positive cells, as well as basal proximal neurites of a subpopulation of layer V GFP-negative cells with relatively large pyramidal-shaped somata (Supplementary Material, Fig. S2 ). These observations suggest that in the neocortex, Nav1.1 is expressed in axons and somata of a subpopulation of layer V pyramidal excitatory neurons, in addition to PV inhibitory neurons.
At postnatal week 8, differences in Nav1.1 immunoreactivity in the hippocampus and neocortex of Scn1a fl/fl and Scn1a fl/fl , Emx1-Cre mice became more apparent ( Fig. 6E-J ). In the hippocampus of Scn1a fl/fl mice, we observed a band of diffuse Nav1.1 immunoreactivity extending from the stratum lacunosummoleculare within the CA fields to the dentate gyrus molecular layer (Fig. 6Ea) , which would correspond to perforant path fibers arising from excitatory neurons of the entorhinal cortex, crossing the stratum lacunosum-moleculare in the hippocampal CA1 field and terminating in the lacunosum-moleculare in the hippocampal CA3 field or molecular layer of the dentate gyrus (30, 31) . As the middle one-third of the dentate gyrus molecular layer in Scn1a fl/fl controls was clearly Nav1.1-immunoreactive, excitatory neurons in the medial (rather than the lateral) entorhinal cortex appear to express Nav1.1 in their perforant afferents (31, 32) . In Scn1a fl/fl , Emx1-Cre mice, Nav1.1 immunoreactivity in the perforant path was reduced compared with Scn1a f l/f l controls ( Fig. 6Fa) , whereas Nav1.1 signals in axon arborizations of PV basket cells were largely maintained ( Fig. 6Eb and Fb). These observations, together with the occurrence of Cre-loxP recombination in excitatory neurons in the entorhinal cortex in the Emx1-Cre driver line (26) , suggest Nav1.1 is expressed in the perforant path of medial entorhinal cortex excitatory neurons.
Previous studies have shown that hippocampal pyramidal cells and dentate gyrus granule cells express Nav1.1 in their somata and dendrites (14, 18, 33, 34) . In contrast, other studies failed to detect Nav1.1 in somata and proximal neurites of most, if not all, hippocampal and dentate gyrus excitatory cells (15,35 -37) . In agreement with the latter studies, our immunohistochemical analysis also failed to detect any distinctive Nav1.1 immunoreactivity in somata and proximal neurites of hippocampal and dentate gyrus excitatory neurons in Scn1a In the neocortex at postnatal week 8, diffuse Nav1.1 immunoreactivity in layers II/III and V was lower in Scn1a fl/fl , Emx1-Cre mice (Fig. 6H ), compared with Scn1a fl/fl controls (Fig. 6G ). Nav1.1-immunoreactive AIS-like fibers were not found in any neocortical layers from either genotype. Axons of excitatory neurons in neocortical layers II/III and V arborize in layers II/III and V (38) (39) (40) ; therefore, our results may suggest these axonal arborizations express Nav1.1.
We also performed immunohistochemical analysis on coronal brain sections of 8-week-old Scn1a fl/fl and Scn1a fl/fl , Emx1-Cre mice ( Fig. 6I and J) . Diffuse Nav1.1 immunoreactivity in the corpus callosum was observed in Scn1a fl/fl controls and was reduced in Scn1a fl/fl , Emx1-Cre mice, suggesting that Nav1.1 is expressed in callosal axons of neocortical excitatory neurons. In Scn1a fl/fl mice, we also detected columnar structures of diffuse Nav1.1 immunosignal in layer IV and at the boundary between layers V and VI, in barrel fields of somatosensory cortex (Fig. 6Ib) , where axons of thalamo-cortical excitatory projection neurons arborize (41), suggesting Nav1.1 localizes in these axonal arborizations. In Scn1a fl/fl , Emx1-Cre mice, diffuse Nav1.1 immunoreactivites in neocortical layers II/III and V were reduced, yet the distinctive Nav1.1-immunoreactive columnar structures still detected (Fig. 6Jb) , consistent with the previous observation that no Cre-loxP recombination was detected in thalamo-cortical neurons in the Emx1-Cre driver line (26) .
Additional Nav1.1 deletion in excitatory neurons of mice with Nav1.1 haploinsufficiency in global inhibitory neurons ameliorates seizure-related sudden death (Fig. 7) . This suggests that Nav1.1 haploinsufficiency in Emx1-lineage forebrain excitatory neurons reduces the risk of seizure-related sudden death.
Selective Nav1.1 deletion in PV cells causes spontaneous epileptic seizures and ataxia in mice
To selectively delete Nav1.1 in PV cells, we employed a PV-Cre driver line, Pvalb-Cre BAC transgenic (PV-Cre-TG) mice, in which Cre-loxP recombination occurs in the majority of PV cells (42) . PCR analysis of DNA from Scn1a fl/fl , PV-Cre-TG , Emx1-Cre (F) hippocampi, and 8-week-old Scn1a fl/fl (G) and Scn1a fl/fl , Emx1-Cre (H) neocortices, stained with anti-Nav1.1 antibody. Higher magnification images outlined in (a) are shown in (b). Scale bars: (a) 400 mm; (b) 40 mm. Arrowheads indicate the Nav1.1-immunoreactive bands extending from the stratum lacunosum-moleculare within the CA fields to the molecular layer of dentate gyrus, which virtually correspond to the hippocampal perforant path. DG, dentate gyrus; o, stratum oriens; p, stratum pyramidale; l, stratum lucidum; r, stratum radiatum; lm, stratum lacunosum-moleculare; m, dentate gyrus molecular layer; g, dentate gyrus granule cell layer. (I and J) Representative coronal sections of 8-week-old Scn1a fl/fl (I) and Scn1a fl/fl , Emx1-Cre (J) brains stained with anti-Nav1.1 antibody (n ¼ 3 per genotype). Arrowheads and arrows indicate the Nav1.1-immunoreactive bands, which correspond to hippocampal perforant path and corpus callosum, respectively. Higher magnification images outlined in (a) are shown in (b). Note that reductions in Nav1.1 immunostaining intensities in the medial perforant pathway, corpus callosum and neocortical layers II/III, V and VI in Scn1a fl/fl , Emx1-Cre mice were observed in comparison with Scn1a fl/fl controls. CC, corpus callosum; DG, dentate gyrus; S1BF, primary somatosensory cortex, barrel field. Scale bars: 100 mm. Nuclear immunosignals are non-specific (15) . Parasagittal images are oriented from the pial surface (top) to the callosal (bottom), and from rostral (left) to caudal (right). Coronal images are oriented from lateral (left) to medial (right). fl, floxed allele. whole brain verified PV-Cre-TG-dependent recombination of the floxed Scn1a allele (Fig. 8A) . Western blot analysis showed that Nav1.1 expression in P21.5 Scn1a fl/fl ,PV-Cre-TG whole brain was reduced to 51.4 + 2.1% level of that in Scn1a fl/fl littermates ( Fig. 8B and C) . Homozygotes (Scn1a fl/fl , PV-Cre-TG) were viable with no obvious abnormal phenotypes in the first postnatal week. However, they developed ataxia and spontaneous generalized convulsive seizures around P10 and P14, respectively ( Fig. 8D and E) , and all died before P30 (Fig. 8F) . Heterozygotes (Scn1a fl/+ ,PV-Cre-TG) were viable until the second postnatal week, but some developed recurrent seizures and suffered sporadic sudden death after P16 (Fig. 8F) . Thus, the phenotypes of homozygote and heterozygote mice are similar to, or even milder (for example, showing delayed seizure onset) than, those of previously reported constitutional Nav1.1-homozygous and heterozygous knock-out mice, respectively (14, 15) .
Immunohistochemical analysis on the hippocampus and neocortex of Scn1a fl/fl ,PV-Cre-TG and Scn1a fl/fl mice at P12.5 (before the development of epileptic seizures in Scn1a fl/ fl ,PV-Cre-TG mice) detected weak Nav1.1 immunoreactivities on fibers and puncta, scattered within the stratum oriens, pyramidale and radiatum of hippocampal CA fields, as well as in neocortical layers II/III, IV, V and VI. The patterns and intensities of the antibody signals showed no obvious genotype differences (Fig. 9A-D) , and provide a likely explanation for the lack of seizure development in Scn1a fl/fl ,PV-Cre-TG, compared with Scn1a d/d mice, at this developmental stage. It also suggests that transgenic PV promoter-driven Cre-loxP recombination in the hippocampus and neocortex scarcely occurs at P12.5, consistent with previous reports that PV expression in hippocampal and neocortical cells begins in the second and third postnatal weeks (43) (44) (45) .
At P16.5, when seizures begin in Scn1a fl/fl ,PV-Cre-TG mice, intensities of hippocampal Nav1.1 immunosignals appeared moderately reduced in Scn1a fl/fl ,PV-Cre-TG mice, compared with age-matched Scn1a fl/fl mice ( Fig. 9E and F) . In contrast, neocortical Nav1.1 immunostaining intensities and patterns remained similar between genotypes ( Fig. 9G and H) .
At P21.5, when Scn1a
,PV-Cre-TG mice suffer recurrent seizures and sporadic sudden death, genotype differences in Nav1.1 immunostaining patterns and intensities in the (Fig. 9I-L) . In the hippocampus, Nav1.1-immunoreactive fibers and puncta in CA fields, presumably axons of PV basket cells, were strongly detected in Scn1a fl/fl , but almost absent in Scn1a fl/fl , PV-Cre-TG mice ( Fig. 9I and J) . In the neocortex, Nav1.1 immunoreactivity was often localized in neurites oriented toward the pial surface in Scn1a fl/fl mice, but this localization was not distinctly detected in Scn1a fl/fl , PV-Cre-TG mice (Fig. 9K -N) , providing further evidence that neocortical PV cells express Nav1.1 (15) . In contrast, fibrous Nav1.1 immunoreactivity was occasionally detected in downward projecting basal neurites of layer V cells in both Scn1a fl/fl and Scn1a fl/fl , PV-Cre-TG mice ( Fig. 9M and N ). Taken together with our observations that downward projecting basal neurites with Nav1.1 immunoreactivity were rarely observed in Scn1a fl/fl , Emx1-Cre mice (see Fig. 6Db ), Nav1.1 appears to be expressed in a subset of neocortical layer V PV-negative, excitatory pyramidal neurons, consistent with recent studies (18, 19) . It is notable that the diffuse backgroundlike signal, presumably a signal in distal axons of excitatory neurons (see also Fig. 6I and J) , remained high, or became even higher, in both genotypes compared with those at P16.5. In addition, Nav1.1 immunoreactivities at neocortical layer IV, and between layers V and VI, reflecting signals in arborized axons of thalamo-cortical projection neurons (41) , and reported as PV-positive (42), were moderately reduced in Scn1a fl/fl , PV-Cre-TG mice, compared with Scn1a fl/fl mice ( Fig. 9Ka and La). Immunofluorescent examination of Nav1.1 colocalization with PV and ankyrin-G, a marker for AISs, in P21.5 Scn1a fl/fl controls, confirmed marked Nav1.1 immunopositivity in AISs of neocortical PV cells (Fig. 9O) , reported previously at P14 -16 (15) . In contrast, a significant reduction in Nav1.1 immunostaining intensities was observed in AISs of most neocortical PV cells in P21.5 Scn1a fl/fl , PV-Cre-TG mice (Fig. 9P ). In the cerebellum at P12.5, when Scn1a fl/fl , PV-Cre-TG mice suffer severe ataxia, differences in Nav1.1 immunostaining patterns and intensities were observed between Scn1a fl/fl and Scn1a fl/fl , PV-Cre-TG mice (Fig. 9Q and R) . Nav1.1-immunoreactive fibers and puncta distributed in the inner molecular layer of cerebellar lobes, presumably corresponding to PV-expressing cerebellar basket cells (15, 46) , were clearly observed in Scn1a , PV-Cre-TG mice ( Fig. 9Qc and Rc). Intensities of Nav1.1 immunoreactivities on puncta scattered within cerebellar nuclei and white matter, comprising projecting axons from cerebellar Purkinje cells (47) , were reduced in Scn1a fl/fl , PV-Cre-TG mice, compared with Scn1a fl/fl mice ( Fig. 9Qd and Rd). We also crossed floxed Scn1a mice with Pvalb-Cre knock-in (PV-Cre-KI) mice (48) , in which the PV-Cre knock-in allele harbors an internal ribosome entry site (IRES) and Cre recombinase inserts into the 3 ′ UTR of the mouse Pvalb gene. Endogenous Pvalb promoter-driven Cre-loxP recombination occurs only , PV-Cre-KI whole brain verified PV-Cre-KI-dependent recombination of the floxed Scn1a allele (Fig. 10A) . Western blot analysis showed that Nav1.1 expression levels in Scn1a fl/fl , PV-Cre-KI mouse whole brain at P21.5 and 8 weeks were 98.9 + 6.4 and 87.6 + 4.3% of those in age-matched Scn1a fl/fl control littermates, respectively, although the slight reduction at 8 weeks was not statistically significant (Fig. 10B and C) . Scn1a fl/fl , PV-Cre-KI mice were viable with no obvious abnormal phenotypes until the beginning of the third postnatal week. The mice developed spontaneous recurrent convulsive seizures with abnormal ECoG patterns around P20 (Fig. 10D and E) . In addition, the mice exhibited abnormal interictal poly-spike-wave discharges, which were most pronounced during resting or sleeping (Fig. 10F) . At around P20, Scn1a fl/fl , PV-Cre-KI mice developed ataxia, which was clearly observed in inclined (an 458 angle) cages. Scn1a fl/fl mice walked up and down the slope with a steady gait; however, in contrast, although Scn1a fl/fl , PV-Cre-KI mice were able to climb up the slope, they always slipped down the slope with an unstable gait. Some Scn1a fl/fl , PV-Cre-KI mice suffered sporadic sudden death after P25 (Fig. 10G) . These results suggest that a minimal amount of Nav1.1 deletion, specifically in PV cells, is enough to cause spontaneous epileptic seizures, ataxia and occasional sudden death.
The spatial and temporal patterns of Nav1.1 expression were examined by immunohistochemistry in Scn1a fl/fl , PV-Cre-KI brain parasagittal sections. At P16.5, before Scn1a fl/fl , PV-Cre-KI mice developed epileptic seizures, Nav1.1 immunostaining intensities and patterns in the hippocampus and neocortex of Scn1a fl/fl , PV-Cre-KI mice were similar to those in age-matched Scn1a fl/fl controls ( Fig. 11A-D) . This is in agreement with late onset of endogenous PV promoter-driven Cre-loxP recombination in the hippocampus and neocortex (52) , and provides a plausible explanation for the lack of seizures in Scn1a fl/fl , PV-Cre-KI mice at this postnatal stage, despite Scn1a d/d mice of the same age suffering recurrent seizures (see Fig. 1D and E). In Scn1a fl/fl mice, , PV-Cre-KI mice began to suffer recurrent seizures, Nav1.1-immunoreactive fibers in hippocampal CA fields, presumably axons of PV-positive fast-spiking basket cells (15) , were observed in Scn1a fl/fl mice (Fig. 11E ), but reduced in Scn1a fl/fl , PV-Cre-KI mice (Fig. 11F) . This is consistent with Nav1.1 localization in axons of hippocampal PV inhibitory neurons within the stratum oriens and pyramidale (53-55) in wild-type mice (15, 37) . In contrast, staining intensities and patterns in Nav1.1-immunoreactive fibers and puncta scattered within the neocortex appeared similar between genotypes at this stage ( Fig. 11G and H) , suggesting that modest reductions in Nav1.1 expression levels in hippocampal PV interneurons are sufficient to cause epileptic seizures in mouse.
At postnatal week 8, differences in Nav1.1 immunostaining patterns in the hippocampus of Scn1a fl/fl , PV-Cre-KI and Scn1a fl/fl mice became more evident ( Fig. 11I and J) . Nav1.1-immunoreactive fibers and puncta scattered in hippocampal CA fields were observed in Scn1a fl/fl mice, but virtually undetected in Scn1a fl/fl , PV-Cre-KI mice. Moreover, the band of diffuse Nav1.1 immunoreactivity extending from the stratum lacunosummoleculare of hippocampal CA fields to the molecular layer of the dentate gyrus was detected similarly in both genotypes (Fig. 11Ia and Ja). These diffuse Nav1.1 immunoreactivities are assumed to be the perforant path (30,31) (see also Fig. 6Ea and Fa). In the neocortex at postnatal week 8, overall Nav1.1 immunostaining intensities appeared subtly decreased in Scn1a fl/fl , PV-Cre-KI mice, compared with Scn1a fl/fl mice ( Fig. 11K and L) . In the cerebellum at P21.5, a stage when Scn1a fl/fl , PV-Cre-KI mice display ataxia, differences in Nav1.1 immunostaining intensities were observed between Scn1a fl/fl and Scn1a fl/fl , PV-Cre-KI mice (Fig. 11M and N) . Nav1.1 immunoreactivities in fibers and puncta distributed in the inner molecular layer of cerebellar lobes, putatively corresponding to axons of PV-expressing cerebellar basket cells (15, 46) , appeared weaker in Scn1a fl/fl , PV-Cre-KI mice than in Scn1a fl/fl mice (Fig. 11Ma-c and Na-c). Also, Nav1.1-immunoreactive puncta scattered in cerebellar nuclei and white matter, comprising PV-expressing cerebellar Purkinje cells axons (47) , appeared reduced in Scn1a fl/fl , PV-Cre-KI mice, compared with Scn1a fl/fl mice ( Fig. 11Md and Nd).
All of the phenotypic and immunohistochemical data on a series of conditional Scn1a mutant mice obtained in the present study were summarized in Tables 1 and 2 .
DISCUSSION
Our study on a series of conditional Scn1a knock-out mice provides important insights into the pathology of Dravet syndrome. Mice with selective Nav1.1 deletion in global inhibitory neurons (using VGAT-Cre recombination) suffered epileptic seizures with a significantly higher risk of lethality than constitutive Scn1a knock-out mice. Nav1.1 deletion in mouse excitatory neurons (using Emx1-Cre recombination) did not cause epileptic seizures or any other observable behavioral abnormalities, but ameliorated the significant lethality of Nav1.1 deletion in global inhibitory neurons (using combined Emx1-Cre and VGAT-Cre-dependent recombination) (Tables 1 and 2 ). These findings show for the first time the protective or ameliorating effect of Nav1.1 haploinsufficiency in excitatory neurons on the risk of SUDEP in Dravet syndrome.
Cheah et al. (19) recently showed inhibitory neuron-specific Nav1.1 deletion in mice, using the Dlx1/2-I12b-Cre driver (Scn1a fl/+ ,Dlx-Cre), which caused spontaneous epileptic seizures and premature lethality, although the phenotype of Scn1a f/+ , Dlx-Cre mice was milder than that of Scn1a f/+ , VGAT-Cre mice, and more comparable with constitutive heterozygous Scn1a knock-out mice. Dlx1/2-I12b-Cre expresses Cre recombinase in the majority of GABAergic inhibitory neurons, including PV-, somatostatin-, neuropeptide Y-and calretininpositive cells (20) . Given that Dlx1/2-I12b-Cre-mediated Nav1.1 deletion occurs in 50% of forebrain inhibitory neurons (19) , phenotypic differences between Scn1a 
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Human 14, 15) . The study on Scn1a fl/+ , Dlx-Cre mice (19) also found Nav1.1 expression in certain excitatory neurons, including layer V pyramidal cells; however, they did not discuss a functional role of Nav1.1 in excitatory neurons, with regard to epileptic phenotypes.
Dutton et al. (18) reported another conditional Nav1.1 inactivation in mice, using the Ppp1r2-Cre driver that preferentially induces Cre-loxP recombination in a subset of forebrain GABAergic inhibitory neurons consisting of 75, 30 and 15% of total PV-, reelin-and neuropeptide Y-positive cells (21) . Scn1a fl/+ ,Ppp1r2-Cre mice show increased flurothyl-and hyperthermia-induced seizure susceptibilities, and develop infrequent seizures. However, the mice do have a normal lifespan and less spontaneous seizures compared with constitutive Scn1a knock-out mice (18) . This milder phenotype could be due to restricted or incomplete Nav1.1 deletion by Ppp1r2-Cre, as discussed by the authors (18). Dutton et al. (18) also generated Scn1a fl/+ , Emx1-Cre mice, reporting that the mice had normal susceptibility levels of flurothyl-and hyperthermia-induced seizures, not consistent with our observation of an ameliorating effect of Emx1-Cre-dependent Nav1.1 deletion in Scn1a fl/+ , VGAT-Cre mice. It is possible that the protective effect of Nav1.1-haploinsufficient forebrain excitatory neurons is only observed when seizures are generated spontaneously or in distinct pathologies, and may partially explain the conflicting results. Alternatively, seizure generation and seizure-related sudden death may involve distinct neuronal circuits or networks. Further studies are needed to investigate the nature of these discrepancies.
Our study also showed that minimal PV-positive cell-specific Nav1.1 deletion, using PV-Cre-KI, is sufficient to cause spontaneous epileptic seizures and ataxia in mice (Tables 1 and 2) , further supporting our previous proposal that functional impairment of PV interneurons is the basis for epileptic seizures in Dravet syndrome (15) . PV has been widely used as a specific biochemical marker for a subclass of forebrain GABAergic inhibitory neurons that can also be grouped electro-physiologically as fast-spiking neurons, or morphologically as basket cells and chandelier cells. In Pvalb-IRES-Cre lines, for example, the PV-Cre-KI mice used in our study, endogenous Pvalb promoterdriven Cre-loxP recombination occurs only in subsets of PV inhibitory neurons expressing high PV levels and with large somata (49) , suggesting incomplete Nav1.1 deletion in PV inhibitory neurons of Scn1a fl/fl , PV-Cre-KI mice. In the PV-Cre-TG driver line, transgenic Pvalb promoter-driven Cre-loxP recombination occurs in the majority of PV cells and, to a much lesser extent, in PV-negative cells, including a subpopulation of somatostatin-positive inhibitory neurons (42) . Higher efficiency or more widespread occurrence of Cre-loxP recombination in PV-Cre-TG, than PV-Cre-KI, driver line likely accounts for the greater amount of PV-Cre-dependent Nav.1.1 reduction in Scn1a fl/fl , PV-Cre-TG mice than in Scn1a fl/fl , PV-Cre-KI mice (Tables 1 and 2 ). Differences in Cre-loxP recombination efficiency in PV inhibitory neurons appear to contribute to differences in phenotypic severity between Scn1a fl/fl ,VGAT-Cre mice had an earlier onset of a reduction in Nav1.1 expression levels in both the hippocampus and neocortex, consistent with RNA in situ hybridization data showing detectable VGAT expression in the forebrain in the first postnatal week, before the onset of PV expression (Allen Developing Mouse Brain, http://developingmouse.brain-map. org/). Second, the milder phenotype observed in Scn1a fl/fl , PV-Cre-TG mice may be facilitated by the ameliorating effect of Nav1.1 deletion in PV-positive excitatory neurons. In addition to PV interneurons, PV expression is found in several excitatory neuronal subtypes, including a small subpopulation of neocortical layer V excitatory neurons and thalamo-cortical excitatory projection neurons (42, 49, 56) . Our study shows Nav1.1 expression in neocortical layer V excitatory neurons, consistent with previous studies (18, 19) , and thalamo-cortical projection neurons. As discussed, our results with VGAT-and Emx1-double-Cre mice suggest that Nav1.1 haploinsufficiency in excitatory pyramidal cells may have an ameliorating effect on seizures. Given that impaired function of thalamo-cortical projection neurons has a protective influence on seizure pathology (57), Nav1.1 deletion in thalamo-cortical PV projection neurons may contribute to amelioration of epileptic seizures and seizure-related lethality in Scn1a fl/fl , PV-Cre-TG mice. This possible ameliorating effect of Nav1.1 deletion in thalamocortical PV projection neurons can also contribute to the better survival rate in Scn1a ,VGAT-Cre mice. A caveat to this is that we did not detect Nav1.1 expression in PV-negative interneurons by immunohistochemistry. Further studies are required to determine the role of PV-negative interneurons in Dravet syndrome mouse models and patients.
It has been known that genetic backgrounds largely affect seizure severity in the mice with Nav1.1 haploinsufficiency (14, 15) . In our previous study (15) , the mixed C57BL6/129 (75%/25%) background resulted in 25% lethality at 1 week of age and 40% at 3 weeks, whereas the 129 dominant mixed background (C57BL6/129 ¼ 25%/75%) did not lead to premature lethality. In this study, because all of the conditional knock-out mouse lines have similar levels of C57BL6/129 (Table 1) , contribution of genetic backgrounds to the phenotypic differences among the conditional lines seems to be minimal.
In summary, the present study showed, for the first time, that Nav1.1 haploinsufficiencies in excitatory and inhibitory neurons are both involved in the pathology of Dravet syndrome. Although therapeutic approaches to compensate for Nav1.1 haploinsufficiency are potential treatments for Dravet syndrome, our results highlight the need for preferential targeting of therapeutic approaches to inhibitory, rather than excitatory neurons. We also show that a minimal amount of Nav1.1 deletion in PV cells is enough to cause spontaneous epileptic seizures in mouse, supporting our previous proposal that functional impairments of PV interneurons are the circuit basis for the epileptic pathology of Dravet syndrome, and further proposing PV interneurons as promising therapeutic targets.
MATERIALS AND METHODS
Gene targeting and mice
Mice were handled in accordance with the guidelines of the Animal Experiment Committee of RIKEN Brain Science Institute and National Institute of Genetics.
The P1-derived artificial chromosome (PAC) clones (460H9, 569J7 and 306M11) were isolated by screening a pooled mouse genomic PAC library (BACPAC Resource Center, Oakland, CA, USA) by dot blot hybridization using the probe corresponding to the genomic fragment containing the Scn1a coding exon Table 2 . Nav1.1 immunostaining patterns observed in conditional Scn1a mutant mice generated in this study Genotype The targeting vector was linearized with SacII and transfected into 129P2/Ola-derived embryonic stem (ES) cells using a GenePulser (Bio-Rad, Hercules, CA, USA) at 3 mF and 800 V. Transfected ES cells were plated on neomycin-resistant, mitomycin C-treated mouse embryonic feeder cells (MEF). One day after plating, positive selection was performed in the presence of 150 mg/ml of Geneticin (G418; Life Technologies, Carlsbad, CA, USA). Resistant clones were picked at day 7, subsequently expanded into 24-well plates pre-seeded with MEF, and screened by Southern blotting (using both 5 ′ and 3 ′ probes located outside the targeting construct) and PCR analysis. Cells from three independent positive clones (1C12, 6A8 and 6G10) were injected into C57BL/6J blastocysts, which were transferred into pseudopregnant female recipient ICR mice. Each ES clone produced male chimeras with .50% agouti coat color, which were bred to C57BL/6J females to allow for the detection of germline transmission. F1 mice heterozygous for the targeted allele were obtained and crossed with CAG-FLPe deleter mice on a C57BL/6J background (58) d/+ mice. VGAT (also known as vesicular inhibitory amino acid transporter, Viaat)-Cre BAC transgenic mice were generated using a BAC Tg construct made with the Red/ET recombination system (Gene Bridges, GmbH, Dresden, Germany), as previously described (59) . Briefly, the Cre-Km cassette, containing Cre recombinase followed by SV40 poly(A) and kanamycinresistant genes, was PCR-amplified using DNA polymerase Pyrobest (Takara Bio) and the primer set: 5 ′ -TCC TCG CTG CCT TGA CGC GCG CCC GCC GCG TCC CCA GAC CCT TCT GTC CTT TTC TCT CGA CCT GCA GCC CAA GCT GTA CC-3 ′ and 5 ′ -GGC CTG GGA CTT GTT GGA CAC GGA GGT GGC CAC ATT GGT CAG CTT GCT GCG GAG CAC TAA ATA CAT TCA AAT ATG TAT CC-3
′ . An Escherichia coli strain, containing an RP23-392-P11 BAC clone derived from C57BL/6 mouse genomic DNA (Roswell Park Center Institute, Buffalo, NY, USA) and covering 124 kb upstream and 72 kb downstream of the translational initiation site of the Vgat gene, was transformed with pSC101-BAD-gbaA (Gene Bridges) and subsequently with purified PCR products. The resulting BAC Tg construct was verified by restriction enzyme digestion and DNA sequencing. The construct was linearized by PI-SceI and purified using Sepharose columns. The fraction containing the Tg construct was identified by pulsed-field gene electrophoresis (FIGE Mapper, Bio-Rad). The purified DNA fragment was injected into pronuclei of fertilized eggs from C57BL/6 mice to generate Tg mice. Tg65, the Tg mouse line used in this study, has been maintained on a C57BL/6 genetic background. Heterozygous (Scn1a fl/+ ,VGAT-Cre) mice were obtained by cross-mating Scn1a fl/fl mice and VGAT-Cre mice. Homozygous (Scn1a fl/fl ,VGAT-Cre) mice were generated as described below.
Emx1-Cre KI mice without a neomycin cassette were described previously (26, 60, 61) , and maintained on a C57BL/ 6J background. Heterozygous (Scn1a fl/+ , Emx1-Cre) mice were obtained by cross-mating Scn1a fl/fl mice and Emx1-Cre mice, and subsequently backcrossed with Diagnostics) for 12-15 h at 48C. Endogenous peroxidases were quenched by incubation with 0.3% hydrogen peroxide in PBS. Detection of antibody-antigen complexes was performed using the Vectastain ABC-AP kit (Vector Laboratories), containing Vector NovaRed substrates and producing red reaction products, and the alkaline phosphatese substrate kit III (Vector Laboratories) containing Vector Blue substrates and producing blue reaction products, according to the manufacturer's instructions.
